By expenditures
| Name | Title | Type |
|---|---|---|
| Lan Eberle | Superintendent | Auditee |
| Jason Hohulin | Shareholder | Auditee |
| Suzanne Steckel | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 350314 | 2024 | 2025-03-29 | Gorenz & Associates LTD | $873,195 |
| 298764 | 2023 | 2024-03-27 | Gorenz and Associates LTD | $886,731 |
| 24330 | 2022 | 2022-12-12 | Zumbahlen Eyth Surratt Foote and Flynn LTD | $1.88M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 350314 | 2024 | 2025-03-29 | 1117004 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 1117003 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 1117002 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 1117001 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 1117000 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 1116999 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 1116998 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540562 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540561 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540560 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540559 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540558 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540557 | 2024-002 | Significant Deficiency | Yes | I |
| 350314 | 2024 | 2025-03-29 | 540556 | 2024-002 | Significant Deficiency | Yes | I |
| 298764 | 2023 | 2024-03-27 | 962866 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 962865 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 962864 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 962863 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 962862 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 962861 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 962860 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386424 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386423 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386422 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386421 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386420 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386419 | 2023-002 | Significant Deficiency | - | I |
| 298764 | 2023 | 2024-03-27 | 386418 | 2023-002 | Significant Deficiency | - | I |
| 24330 | 2022 | 2022-12-12 | 609357 | 2022-003 | Material Weakness | Yes | P |
| 24330 | 2022 | 2022-12-12 | 32915 | 2022-003 | Material Weakness | Yes | P |